Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts
Main Authors: | Ziegelasch, Michael, van Delft, Myrthe A. M., Wallin, Philip, Skogh, Thomas, Magro-Checa, César, Steup-Beekman, Gerda M., Trouw, Leendert A., Kastbom, Alf, Sjöwall, Christopher |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135817/ |
Similar Items
-
Circulating secretory IgA antibodies against cyclic citrullinated peptides in early rheumatoid arthritis associate with inflammatory activity and smoking
by: Roos, Karin, et al.
Published: (2016) -
Associations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register
by: Frodlund, Martina, et al.
Published: (2013) -
C1q Deficiency and Neuropsychiatric Systemic Lupus Erythematosus
by: van Schaarenburg, Rosanne A., et al.
Published: (2016) -
Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives
by: Magro-Checa, César, et al.
Published: (2016) -
Citrullination and Carbamylation in the Pathophysiology of Rheumatoid Arthritis
by: Pruijn, Ger J. M.
Published: (2015)